Ranistha RatanaratChaisith SivakornTanuwong ViarasilpaMarcus J. SchultzMahidol UniversityFaculty of Medicine, Siriraj Hospital, Mahidol UniversityNuffield Department of MedicineAmsterdam UMC - University of Amsterdam2020-08-252020-08-252020-07-01The American journal of tropical medicine and hygiene. Vol.103, No.1 (2020), 48-54147616452-s2.0-85088206040https://repository.li.mahidol.ac.th/handle/20.500.14594/57954Since late December 2019, the world has been challenged with an outbreak of COVID-19. In Thailand, an upper middle-income country with a limited healthcare infrastructure and restricted human resources, nearly 3,000 confirmed COVID-19 cases have been reported as of early May 2020. Public health policies aimed at preventing new COVID-19 cases were very effective in halting the pandemic in Thailand. Case fatality in Thailand has been low (1.7%), at least in part due to early stratification according to risk of disease severity and timely initiation of supportive care with affordable measures. We present our initial experience with COVID-19 in Thailand, focusing on several aspects that may have played a crucial role in curtailment of the pandemic, and elements of care for severely ill COVID-19 patients, including stratification, isolation, and affordable diagnostic approaches and supportive care measures. We also discuss local considerations concerning some proposed experimental treatments.Mahidol UniversityImmunology and MicrobiologyMedicineArticleSCOPUS10.4269/ajtmh.20-0442